All stock lists
Unlock the score
AbCellera Biologics Inc. (NASDAQ:ABCL)
CA · Delayed Price · Currency is USD
Healthcare · Biotechnology
12.10+0.28 (+2.37%)
Market cap
$3.92B
Insider Score
Analyst consensus
Listed since
Dec 11, 2020
Website
Insider Score
/ 100
ABCL Insider Score
AbCellera Biologics Inc. has a live Insider Score.
Scored on 4 qualifying trades from 3 insiders in the last 90 days.
ABCL analyst forecast
Best analysts covering ABCL
No firm covering ABCL has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ABCL analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| BMO Capital | — | $5.00 | +82.8% | — | 2024-11-05 | |
| KeyBanc | — | $5.00 | +92.7% | — | 2024-08-23 | |
| KeyBanc | — | $7.00 | +82.3% | — | 2024-05-08 | |
| Goldman Sachs | — | $30.00 | +196.2% | — | 2022-12-15 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.